T44.4 Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists
Non-billable header ICD10CM Release FY2026
Short description: Predominantly alpha-adrenoreceptor agonists
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | current | Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists | no |
Related codes in T44
- T44 Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
- T44.0 Poisoning by, adverse effect of and underdosing of anticholinesterase agents
- T44.0X Poisoning by, adverse effect of and underdosing of anticholinesterase agents
- T44.0X1 Poisoning by anticholinesterase agents, accidental (unintentional)
- T44.0X1A Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter
- T44.0X1D Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter
- T44.0X1S Poisoning by anticholinesterase agents, accidental (unintentional), sequela
- T44.0X2 Poisoning by anticholinesterase agents, intentional self-harm
- T44.0X2A Poisoning by anticholinesterase agents, intentional self-harm, initial encounter
- T44.0X2D Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter
- T44.0X2S Poisoning by anticholinesterase agents, intentional self-harm, sequela
- T44.0X3 Poisoning by anticholinesterase agents, assault
- T44.0X3A Poisoning by anticholinesterase agents, assault, initial encounter
- T44.0X3D Poisoning by anticholinesterase agents, assault, subsequent encounter
- T44.0X3S Poisoning by anticholinesterase agents, assault, sequela
- T44.0X4 Poisoning by anticholinesterase agents, undetermined
- T44.0X4A Poisoning by anticholinesterase agents, undetermined, initial encounter
- T44.0X4D Poisoning by anticholinesterase agents, undetermined, subsequent encounter
- T44.0X4S Poisoning by anticholinesterase agents, undetermined, sequela
- T44.0X5 Adverse effect of anticholinesterase agents